Lilin YeLilin Ye

Lilin Ye

Institute of Immunology, Third Military Medical University

Affiliated withThird Military Medical University

Research Area

Cancer ResearchImmunology and Infection

Biography

Lilin Ye has not added Biography.
If you are Lilin Ye and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3
Year
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8<sup>+</sup> T Cells in Mice
Publication title
2021
2024
2024

Other Publications

Article
Year
The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.

Nature immunology| PubMed ID: 26214740

2015
2016
2016
2017
2018
2017
2017
2017
2017
2017
2017
Analyzing Mouse B Cell Responses Specific to LCMV Infection.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 29388097

2018
Flow Cytometry Analysis of mTOR Signaling in Antigen-Specific B Cells.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 29388102

2018
2018
2018
2018
B7S1, a novel candidate for anti-tumor checkpoint blockade immunotherapy.

Science China. Life sciences| PubMed ID: 30069671

2018
2018
A Portrait of CXCR5 Follicular Cytotoxic CD8 T cells.

Trends in immunology| PubMed ID: 30377045

2018
2018
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2021
2020
T cell immune response within B-cell follicles.

Advances in immunology| PubMed ID: 31699216

2019
2020
2020
2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.

Signal transduction and targeted therapy| PubMed ID: 32879307

2020
2020
2021
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
2022
2022
2023
2022
The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells.

Frontiers in cellular and infection microbiology| PubMed ID: 35909969

2022
2022
2022
2022
2022
2022
2023
Bound to be perfect: Lck and T cell co-receptors.

Nature immunology| PubMed ID: 36596893

2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 37728417

2023
2023
2023
2024
2024
2024